Portfolio company
Dioseve
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops induced pluripotent stem cell-derived oocytes and ovarian somatic cells to treat infertility patients who cannot produce viable eggs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vitra Bio
This biotechnology company develops in vitro fertilization technology and cell-based therapies to induce oogenesis outside the ovary for patients struggling with infertility.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
Conception
This biotechnology company develops stem cell technology to generate human eggs from blood cells for individuals and families facing fertility barriers.
Gameto
This biotechnology company develops cell-based therapies and egg maturation protocols for fertility clinics and patients undergoing reproductive treatments.
Paterna Biosciences
Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.
Ovo Labs
This biotech company develops therapeutics to improve egg quality for women undergoing fertility treatments and in vitro fertilisation.
ReproNovo
This biopharmaceutical company develops therapeutic treatments for male and female infertility and uterine conditions for patients worldwide.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
